(Q2347448)

(Redirected from Q104281850)
English

Steven Rosenberg

American cancer researcher

  • Steven A. Rosenberg
  • Steven A Rosenberg
  • S. A. Rosenberg
  • S.A. Rosenberg
  • S A Rosenberg

Statements

0 references
Steven Rosenberg (English)
0 references
0 references
0 references
0 references
0 references
"for breakthrough research advancing chimeric antigen receptor T-cell therapy for the treatment of cancer." (English)
For lifelong scientific achievements and paramount contributions to cancer research and patient care, most notably his pioneering research that established interleukin-2 (IL-2) as the first U.S. Food and Drug Administration (FDA)-approved cancer immunotherapy and his major contributions to establishing fundamental principles involving cellular and genetic engineering and immunotherapeutic development. (English)

Identifiers

1 reference
16 January 2023
0 references
0 references
0 references
0 references
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit